LLYVA vs MSGS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

LLYVA

52.9
AI Score
VS
LLYVA Wins

MSGS

50.5
AI Score

Investment Advisor Scores

LLYVA

53score
Recommendation
BUY

MSGS

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LLYVA MSGS Winner
Forward P/E 126.5823 72.4638 MSGS
PEG Ratio 0 0 Tie
Revenue Growth 6.1% 36.7% MSGS
Earnings Growth 0.0% 644.9% MSGS
Tradestie Score 52.9/100 50.5/100 LLYVA
Profit Margin -108.1% 0.7% MSGS
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD LLYVA

Relative Price Performance (Last 90 Days)

LLYVA 1M: +2.4% · 3M: +1.7% MSGS 1M: -1.3% · 3M: -1.7%

Current Technical Phase

LLYVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.8 · Price: $97.24

MSGS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.4 · Price: $389.48

Fundamentals Snapshot

Metric LLYVA MSGS
Market Cap — —
Forward P/E 126.6 -656.0
Trailing P/E — 1288.7
Revenue (TTM) — —
Revenue Growth 0.1% 0.4%
Gross Margin 0.2% 0.3%
Operating Margin 0.0% 0.1%
EPS -4.77 0.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LLYVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.